Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation

Published:2020-01-24 Issue:6 Volume:107 Page:1405-1419
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Huybrechts Krista F.¹,Gopalakrishnan Chandrasekar¹^ORCID,Bartels Dorothee B.²³⁴,Zint Kristina²,Gurusamy Venkatesh K.²,Landon Joan¹,Schneeweiss Sebastian¹^ORCID

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women’s Hospital Harvard Medical School Boston Massachusetts USA

2. Global Epidemiology Boehringer Ingelheim International GmbH Ingelheim Germany

3. BI X GmbH Ingelheim Germany

4. Hannover Medical School Hannover Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1753

Reference33 articles.

1. Antithrombotic Therapy for Atrial Fibrillation

2. Oral Anticoagulant Therapy